GCP / SOPs / Vendor Qualification
Pharmaxi MRM Inc.operates under a comprehensive Good Clinical Practice (GCP)–compliant quality framework designed to ensure regulatory integrity and operational consistency across all clinical programs. Our organization maintains a structured set of Standard Operating Procedures (SOPs) governing clinical trial conduct, data management, safety reporting, documentation, and quality oversight in alignment with ICH-GCP, FDA, and EMA requirements.
Vendor qualification is conducted through a formal evaluation and approval process that includes capability assessments, quality audits, compliance verification, and ongoing performance monitoring. This ensures that laboratories, technology providers, logistics partners, and other service vendors meet strict quality and regulatory standards. Through disciplined quality governance and validated vendor partnerships, Pharmaxi MRM Inc.ensures reliable and compliant clinical trial execution.
Vendor qualification is conducted through a formal evaluation and approval process that includes capability assessments, quality audits, compliance verification, and ongoing performance monitoring. This ensures that laboratories, technology providers, logistics partners, and other service vendors meet strict quality and regulatory standards. Through disciplined quality governance and validated vendor partnerships, Pharmaxi MRM Inc.ensures reliable and compliant clinical trial execution.
Data Integrity & Security
Pharmaxi MRM Inc.places strong emphasis on data integrity and information security throughout the clinical research lifecycle. All clinical data are managed in validated systems designed to ensure accuracy, traceability, and protection against unauthorized access or alteration. Our processes follow internationally recognized principles including ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate) and comply with ICH-GCP, FDA 21 CFR Part 11, and applicable data protection regulations.
Access controls, audit trails, encrypted data transmission, and secure hosting environments safeguard sensitive clinical information. Regular system validation, data quality checks, and controlled change management procedures ensure that all study data remain reliable, reproducible, and fully inspection-ready for regulatory authorities.
Access controls, audit trails, encrypted data transmission, and secure hosting environments safeguard sensitive clinical information. Regular system validation, data quality checks, and controlled change management procedures ensure that all study data remain reliable, reproducible, and fully inspection-ready for regulatory authorities.
Inspection Readiness
Pharmaxi MRM Inc.maintains continuous inspection readiness to ensure that clinical studies are fully prepared for regulatory review by authorities such as the U.S. FDA, EMA, and other international regulators. Our quality framework includes structured documentation practices, validated systems, and rigorous adherence to ICH-GCP guidelines across all operational processes. Clinical trial documentation is maintained in organized and audit-ready Trial Master Files (TMF/eTMF), with complete traceability of study activities and decisions.
Regular internal audits, quality checks, and staff training programs ensure that teams remain aligned with evolving regulatory expectations. Through proactive quality oversight and comprehensive documentation control, Pharmaxi MRM Inc.enables sponsors to confidently navigate regulatory inspections and maintain full compliance throughout the clinical development process.
Regular internal audits, quality checks, and staff training programs ensure that teams remain aligned with evolving regulatory expectations. Through proactive quality oversight and comprehensive documentation control, Pharmaxi MRM Inc.enables sponsors to confidently navigate regulatory inspections and maintain full compliance throughout the clinical development process.
